반응식
Cl.[NH:2]1[CH2:7][CH2:6][CH:5]([N:8]2[N:12]=[C:11]([CH2:13][O:14][C:15]3[CH:16]=[CH:17][C:18]([N:21]4[CH:25]=[N:24][N:23]=[N:22]4)=[N:19][CH:20]=3)[CH:10]=[N:9]2)[CH2:4][CH2:3]1.[CH3:26][C:27]1[C:31]([S:32](Cl)(=[O:34])=[O:33])=[C:30]([CH3:36])[O:29][N:28]=1>>[N:21]1([C:18]2[N:19]=[CH:20][C:15]([O:14][CH2:13][C:11]3[CH:10]=[N:9][N:8]([CH:5]4[CH2:4][CH2:3][N:2]([S:32]([C:31]5[C:27]([CH3:26])=[N:28][O:29][C:30]=5[CH3:36])(=[O:34])=[O:33])[CH2:7][CH2:6]4)[N:12]=3)=[CH:16][CH:17]=2)[CH:25]=[N:24][N:23]=[N:22]1참가 물질
3
반응물 2
생성물 1
실험 절차
The title compound was synthesized using Intermediate 15 and 3,5-dimethylisoxazole-4-sulfonyl chloride in a similar manner as described in Example 39. 1H NMR (DMSO-d6): δ 10.07 (1H, s), 8.41 (1H, d), 8.00 (1H, d), 7.94 (1H, s), 7.86 (1H, dd), 5.34 (2H, s), 4.65 (1H, m), 3.68 (2H, m), 2.86 (2H, m), 2.61 (3H, s), 2.33 (3H, s), 2.24 (2H, m), 2.00 (2H, m).
출처 및 근거
- ORD 기록
- ord-2b02756a7cda40e39159ac8538f28d64
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846675B2
연결된 노트
불러오는 중…